How to predict proliferative vitreoretinopathy

作者: Riaz Hassan Yusuf Asaria , Chee Hing Kon , Catey Bunce , David G Charteris , David Wong

DOI: 10.1016/S0161-6420(01)00553-X

关键词:

摘要: Abstract Purpose To determine prospectively the accuracy of a predictive risk formula for development postoperative proliferative vitreoretinopathy (PVR) when applied in clinical setting. Design Prospective noncomparative interventional case series. Participants Two hundred nineteen subjects undergoing primary vitrectomy rhegmatogenous retinal detachment were studied. Method By use formula-based discriminant rule, classified as either high or low PVR. All followed prospectively. Outcome measures Development PVR defined by updated Retina Society Classification. Results Complete data available on 212 219 subjects. There 130 identified and 82 risk; 9.2% low-risk (12 130) compared with 28% (23 82) high-risk had develop. This difference was statistically significant ( P Conclusions Our study has shown that using model it is possible to identify at greater developing after vitrectomy.

参考文章(15)
W Kosnosky, V A Pakalnis, A Fox, R C Hunt, T H Li, Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes. Investigative Ophthalmology & Visual Science. ,vol. 35, pp. 4260- 4267 ,(1994)
D. J. H. Kauffmann, C. Master, D. A. E. Mertens, M. E. Gerritsen, E. Peperkamp, J. C. Van Meurs, Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Investigative Ophthalmology & Visual Science. ,vol. 35, pp. 900- 906 ,(1994)
Riaz Hassan Yusuf Asaria, Chee Hing Kon, Catey Bunce, David G Charteris, David Wong, Peng Tee Khaw, George William Aylward, Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial Ophthalmology. ,vol. 108, pp. 1179- 1183 ,(2001) , 10.1016/S0161-6420(01)00589-9
George Hilton, Robert Machemer, Ronald Michels, Edward Okun, Charles Schepens, Ariah Schwartz, The Classification of Retinal Detachment with Proliferative Vitreoretinopathy Ophthalmology. ,vol. 90, pp. 121- 125 ,(1983) , 10.1016/S0161-6420(83)34588-7
Felipe I. Tolentino, Massive Preretinal Retraction: A Biomicroscopic Study Archives of Ophthalmology. ,vol. 78, pp. 16- 22 ,(1967) , 10.1001/ARCHOPHT.1967.00980030018004
W. F. Rachal, T. C. Burton, Changing concepts of failures after retinal detachment surgery. Archives of Ophthalmology. ,vol. 97, pp. 480- 483 ,(1979) , 10.1001/ARCHOPHT.1979.01020010230008
G A Limb, B C Little, A Meager, J A Ogilvie, R A Wolstencroft, W A Franks, A H Chignell, D C Dumonde, Cytokines in proliferative vitreoretinopathy. Eye. ,vol. 5, pp. 686- 693 ,(1991) , 10.1038/EYE.1991.126
PHILIPPE GIRARD, GÉRARD MIMOUN, IOANIS KARPOUZAS, GUY MONTEFIORE, CLINICAL RISK FACTORS FOR PROLIFERATIVE VITREORETINOPATHY AFTER RETINAL DETACHMENT SURGERY Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 14, pp. 417- 424 ,(1994) , 10.1097/00006982-199414050-00005
A H Chignell, L G Fison, E W Davies, R E Hartley, M F Gundry, Failure in retinal detachment surgery. British Journal of Ophthalmology. ,vol. 57, pp. 525- 530 ,(1973) , 10.1136/BJO.57.8.525
YUKIO YOSHINO, HIDENAO IDETA, HIROSHI NAGASAKI, AKINORI UEMURA, COMPARATIVE STUDY OF CLINICAL FACTORS PREDISPOSING PATIENTS TO PROLIFERATIVE VITREORETINOPATHY Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 9, pp. 97- 100 ,(1989) , 10.1097/00006982-198909020-00004